EP0630254A4 - Verfahren zur ophthalmische wirkstoffabgabe. - Google Patents

Verfahren zur ophthalmische wirkstoffabgabe.

Info

Publication number
EP0630254A4
EP0630254A4 EP94902511A EP94902511A EP0630254A4 EP 0630254 A4 EP0630254 A4 EP 0630254A4 EP 94902511 A EP94902511 A EP 94902511A EP 94902511 A EP94902511 A EP 94902511A EP 0630254 A4 EP0630254 A4 EP 0630254A4
Authority
EP
European Patent Office
Prior art keywords
drug delivery
ophthalmic drug
ophthalmic
delivery
drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP94902511A
Other languages
English (en)
French (fr)
Other versions
EP0630254B1 (de
EP0630254A1 (de
Inventor
Donald Lewis Mackeen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Deo Corp
Original Assignee
Deo Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Deo Corp filed Critical Deo Corp
Priority to EP98113668A priority Critical patent/EP0879601A3/de
Publication of EP0630254A1 publication Critical patent/EP0630254A1/de
Publication of EP0630254A4 publication Critical patent/EP0630254A4/de
Application granted granted Critical
Publication of EP0630254B1 publication Critical patent/EP0630254B1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10—Carbonates; Bicarbonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/42—Phosphorus; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Inorganic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
EP94902511A 1992-12-08 1993-12-07 Zusammensetzungen zur Behandlung des trockenen Auges Expired - Lifetime EP0630254B1 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP98113668A EP0879601A3 (de) 1992-12-08 1993-12-07 Opthalmisches Wirkstoffabgabesystem

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US986932 1992-12-08
US07/986,932 US5366739A (en) 1992-08-06 1992-12-08 Method of ophthalmic drug delivery
PCT/US1993/011873 WO1994013305A1 (en) 1992-12-08 1993-12-07 Method of ophthalmic drug delivery

Related Child Applications (1)

Application Number Title Priority Date Filing Date
EP98113668A Division EP0879601A3 (de) 1992-12-08 1993-12-07 Opthalmisches Wirkstoffabgabesystem

Publications (3)

Publication Number Publication Date
EP0630254A1 EP0630254A1 (de) 1994-12-28
EP0630254A4 true EP0630254A4 (de) 1997-01-15
EP0630254B1 EP0630254B1 (de) 1999-01-27

Family

ID=25532895

Family Applications (2)

Application Number Title Priority Date Filing Date
EP98113668A Withdrawn EP0879601A3 (de) 1992-12-08 1993-12-07 Opthalmisches Wirkstoffabgabesystem
EP94902511A Expired - Lifetime EP0630254B1 (de) 1992-12-08 1993-12-07 Zusammensetzungen zur Behandlung des trockenen Auges

Family Applications Before (1)

Application Number Title Priority Date Filing Date
EP98113668A Withdrawn EP0879601A3 (de) 1992-12-08 1993-12-07 Opthalmisches Wirkstoffabgabesystem

Country Status (7)

Country Link
US (1) US5366739A (de)
EP (2) EP0879601A3 (de)
AU (1) AU677980B2 (de)
CA (1) CA2129635C (de)
DE (1) DE69323303T2 (de)
ES (1) ES2127375T3 (de)
WO (1) WO1994013305A1 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5290572A (en) * 1992-08-06 1994-03-01 Deo Corporation Opthalmic composition for treating dry eye
US5830508A (en) * 1992-08-06 1998-11-03 Deo Corporation Composition for treating dry eye
IT1265647B1 (it) * 1992-11-18 1996-11-22 Farmin Srl Composizione farmaceutiche topiche per le allergie respiratorie
CA2208268A1 (en) * 1994-12-21 1996-06-27 Cosmederm Technologies Formulations and methods for reducing skin irritation
US7404967B2 (en) 1994-12-21 2008-07-29 Cosmederm, Inc. Topical product formulations containing strontium for reducing skin irritation
FR2732598B1 (fr) * 1995-04-10 1997-05-09 Oreal Utilisation de sel de metaux alcalino-terreux pour le traitement des prurits et des dysesthesies oculaires ou palpebraux
US5773019A (en) * 1995-09-27 1998-06-30 The University Of Kentucky Research Foundation Implantable controlled release device to deliver drugs directly to an internal portion of the body
WO2002089767A1 (en) 2001-05-03 2002-11-14 Massachusetts Eye And Ear Infirmary Implantable drug delivery device and use thereof
US20030165545A1 (en) * 2002-01-30 2003-09-04 Allergan, Inc. Ophthalmic compositions including oil-in-water emulsions, and methods for making and using same
US20040191332A1 (en) * 2003-03-27 2004-09-30 Allergan, Inc. Preserved ophthalmic compositions
EP1624938B1 (de) 2003-05-20 2011-03-16 James F. Collins Ophthalmisches arzneimittelabgabesystem
JP2007511295A (ja) * 2003-11-14 2007-05-10 メディカル・インスティル・テクノロジーズ・インコーポレイテッド 注入装置及び注入方法
CN1921833A (zh) * 2004-02-26 2007-02-28 博士伦公司 藻酸盐粘弹性组合物、使用方法及包装
US20050232972A1 (en) * 2004-04-15 2005-10-20 Steven Odrich Drug delivery via punctal plug
CN1819846A (zh) * 2004-05-21 2006-08-16 千寿制药株式会社 包含毒蕈碱性受体激动剂的经皮肤吸收的眼用制剂
US20080132475A1 (en) * 2006-12-05 2008-06-05 Charles Gerald Connor Treatment for dry eye
US9011361B2 (en) 2007-09-07 2015-04-21 Mati Therapeutics Inc. Lacrimal implant detection
US20090118262A1 (en) * 2007-11-01 2009-05-07 Rohrs Brian R Non-Aqueous Water-Miscible Materials as Vehicles for Drug Delivery
KR20100067684A (ko) * 2007-11-05 2010-06-21 보오슈 앤드 롬 인코포레이팃드 약물 전달을 위한 비히클로서의 수불혼화성 물질
US20100016264A1 (en) * 2007-12-05 2010-01-21 Connor Charles G Treatment for dry eye using testosterone and progestagen
US20100323978A1 (en) * 2009-06-22 2010-12-23 Calvin Hanna Non-aqueous oil delivery system for ophthalmic drugs
CA2805426C (en) 2010-07-15 2020-03-24 Corinthian Ophthalmic, Inc. Drop generating device
CA2805635A1 (en) 2010-07-15 2012-01-19 Corinthian Ophthalmic, Inc. Method and system for performing remote treatment and monitoring
KR20130051476A (ko) 2010-07-15 2013-05-20 코린시언 아프샐믹 인코포레이티드 안과용 약물 전달
US10154923B2 (en) 2010-07-15 2018-12-18 Eyenovia, Inc. Drop generating device
US20130172830A1 (en) 2011-12-12 2013-07-04 Corinthian Ophthalmic, Inc. Ejector mechanism, ejector device, and methods of use
US11938056B2 (en) 2017-06-10 2024-03-26 Eyenovia, Inc. Methods and devices for handling a fluid and delivering the fluid to the eye
CA3164288A1 (en) 2019-12-11 2021-06-17 Eyenovia, Inc. Systems and devices for delivering fluids to the eye and methods of use

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1070593A (en) * 1962-12-26 1967-06-01 Olin Mathieson Ophthalmic ointment composition and the preparation thereof
FR2638089A1 (fr) * 1988-10-26 1990-04-27 Sandoz Sa Nouvelles compositions ophtalmiques a base d'une cyclosporine

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5032392A (en) * 1986-09-04 1991-07-16 Vision Pharmaceuticals Aqueous ophthalmic solutions for the treatment of dryness and/or irritation of human or animal eyes
KR920003601B1 (ko) * 1987-09-03 1992-05-04 유니버시티 어브 죠지아 리서취 화운데이션 인코포레이티드 점안 싸이클로스포린(cyclosporin)의 조성물
JP2827295B2 (ja) * 1989-07-04 1998-11-25 大正製薬株式会社 ビタミンａ類含有点眼剤
JP3256997B2 (ja) * 1990-08-30 2002-02-18 千寿製薬株式会社 安定な水性製剤

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1070593A (en) * 1962-12-26 1967-06-01 Olin Mathieson Ophthalmic ointment composition and the preparation thereof
FR2638089A1 (fr) * 1988-10-26 1990-04-27 Sandoz Sa Nouvelles compositions ophtalmiques a base d'une cyclosporine

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
DATABASE DIALOG, FILE 636 Abstract 1261920; XP002017790 *
HARDBERGER R. ET AL: "Effects of drug vehicles on ocular contact time", ARCH.OPHTHAL., 1975, 93/1 (42-45), USA, XP000607501 *
PRODUCT ALERT, VOLUME 21, ISSUED 28 OCTOBER 1991, "BAUSCH & LOMB DRY EYE THERAPY LUBRICATING EYE DROPS MANUFACTURE" *
See also references of WO9413305A1 *
SIEG J W ET AL: "VEHICLE EFFECTS ON OCULAR DRUG BIO AVAILABILITY PART 2 EVALUATION OF PILOCARPINE", J PHARM SCI, 66 (9). 1977 1222-1228., XP000607572 *
SUGAYA M. ET AL: "Kinetics of topical pilocarpine in the human eye", JPN. J. OPHTHALMOL., 1978, 22/1 (127-141), JAPAN, XP000607513 *

Also Published As

Publication number Publication date
EP0879601A3 (de) 2000-08-30
US5366739A (en) 1994-11-22
DE69323303D1 (de) 1999-03-11
CA2129635A1 (en) 1994-06-23
EP0879601A2 (de) 1998-11-25
EP0630254B1 (de) 1999-01-27
CA2129635C (en) 1999-04-27
AU5686394A (en) 1994-07-04
WO1994013305A1 (en) 1994-06-23
DE69323303T2 (de) 1999-09-09
EP0630254A1 (de) 1994-12-28
ES2127375T3 (es) 1999-04-16
AU677980B2 (en) 1997-05-15

Similar Documents

Publication Publication Date Title
AU4111093A (en) Subconjunctival implants for ocular drug delivery
AU8935591A (en) Drug delivery system and method
AU2843095A (en) Method for rapid vascular drug delivery
AU4989993A (en) Drug delivery system
AU6957596A (en) Implantable drug delivery apparatus
AU664807B2 (en) Drug delivery system
AU4227793A (en) Drug infuser
IL110588A (en) Bioadhesive emulsion preparations for enhanced drug delivery
EP0662851A4 (de) ABGABESYSTEM FüR MEDIKAMENTE.
AU7676894A (en) Convection-enhanced drug delivery
GB2303064B (en) Medicament for nasal administration
ZA965931B (en) Transcorneal drug delivery system.
AU4534593A (en) Compositions and methods for enhanced drug delivery
AU5606394A (en) Automated drug infusion system
GB9410236D0 (en) Cytotoxic drug therapy
AU7923794A (en) Iontophoretic drug delivery system and method
AU660290B2 (en) Multiple drug delivery system
EP0600754A3 (de) Pharmazeutische Infusionseinrichtung mit konstantem Durchfluss.
GB9325330D0 (en) Fluorocyclodextrin drug delivery system
EP0636363A3 (de) Verabreichungssystem für Arzneistoffe.
GB9319371D0 (en) Medication administration apparatus
GB9404293D0 (en) Drug delivery system
GB9524942D0 (en) Drug therapy
GB2292887B (en) Drug delivery system
GB9301351D0 (en) An improved method of drug administration

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): CH DE ES FR GB IT LI

17P Request for examination filed

Effective date: 19941214

A4 Supplementary search report drawn up and despatched

Effective date: 19961126

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): CH DE ES FR GB IT LI

17Q First examination report despatched

Effective date: 19970715

GRAG Despatch of communication of intention to grant

Free format text: ORIGINAL CODE: EPIDOS AGRA

GRAG Despatch of communication of intention to grant

Free format text: ORIGINAL CODE: EPIDOS AGRA

GRAH Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOS IGRA

GRAH Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOS IGRA

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): CH DE ES FR GB IT LI

REG Reference to a national code

Ref country code: CH

Ref legal event code: NV

Representative=s name: TROESCH SCHEIDEGGER WERNER AG

Ref country code: CH

Ref legal event code: EP

REF Corresponds to:

Ref document number: 69323303

Country of ref document: DE

Date of ref document: 19990311

REG Reference to a national code

Ref country code: ES

Ref legal event code: FG2A

Ref document number: 2127375

Country of ref document: ES

Kind code of ref document: T3

ITF It: translation for a ep patent filed
ET Fr: translation filed
PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

26N No opposition filed
REG Reference to a national code

Ref country code: GB

Ref legal event code: IF02

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20030129

Year of fee payment: 10

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20030131

Year of fee payment: 10

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: CH

Payment date: 20030203

Year of fee payment: 10

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: ES

Payment date: 20030207

Year of fee payment: 10

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20030212

Year of fee payment: 10

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GB

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20031207

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: ES

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20031209

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20031231

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20031231

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20040701

GBPC Gb: european patent ceased through non-payment of renewal fee

Effective date: 20031207

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20040831

REG Reference to a national code

Ref country code: FR

Ref legal event code: ST

REG Reference to a national code

Ref country code: ES

Ref legal event code: FD2A

Effective date: 20031209

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20051207